期刊文献+

膀胱移行细胞癌中survivin及其剪接变异体survivin-2B和survivin-ΔEx3的表达及意义 被引量:3

下载PDF
导出
摘要 目的:研究survivin及其剪接变异体survivin-2B和survivin-ΔEx3在膀胱移行细胞癌中的表达,探讨其临床意义。方法:应用免疫组化及实时荧光定量PCR检测膀胱移行细胞癌、癌旁和正常膀胱组织survivin、survivin-2B和survivin-ΔEx3表达。结果:Survivin、survivin-2B和survivin-ΔEx3在膀胱移行细胞癌中均表达,与对照组差异有统计学意义。随着病理分级、临床分期升高,survivin和survivin-ΔEx3表达升高(P<0.05),且两者正相关(0<r<1,P<0.05);而survivin-2B的表达则降低(P<0.05)。结论:Survivin、survivin-2B和survivin-ΔEx3可能在膀胱移行细胞癌的发生发展中起不同作用,为膀胱移行细胞癌的诊断治疗提供新的思路。
出处 《实用医学杂志》 CAS 北大核心 2011年第9期1598-1600,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献10

  • 1Karam J A,Lotan Y,Ashfaq R,et al.Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder[J].Urology,2007,70(3):482-486.
  • 2陈智彬,宋永胜.Survivin、Caspase-3、突变型p53对膀胱移行细胞癌预后的意义[J].实用医学杂志,2009,25(3):348-350. 被引量:6
  • 3Kenney D M,Geschwindt R D,Kary M R,et al.Detection of newly diagnosed bladder cancer,bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivin[J].Tumour Biol,2007,28(2):57-62.
  • 4Ling X,Yang J,Tan D,et al.Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer[J].Lung Cancer,2005,49(3):353-361.
  • 5Badran A,Yoshida A,Ishikawa K,et al.Identification of a novel splice variant of the human anti-apoptosis gene survivin[J].Biochem Biophys Res Commun,2004,314(3):902-907.
  • 6Ryan B,O′Donovan N,Browne B,et al.Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer[J].Br J Cancer,2005,92(1):120-124.
  • 7Shariat S F,Casella R,Khoddami S M,et al.Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer[J].J Urol,2004,171(2 Pt 1):626-630.
  • 8Ku J H,Seo S Y,Kwak C,et al.Cytotoxicity and apoptosis by survivin small interfering RNA in bladder cancer cells[J].BJU Int,2010,106(11):1812-1816.
  • 9Span P N,Tjan-Heijnen V C,Manders P,et al.High survivin predicts a poor response to endocrine therapy,but a good response to chemotherapy in advanced breast cancer[J].Breast Cancer Res Treat,2006,98(2):223-230.
  • 10Caldas H,Jiang Y,Holloway M P,et al.Survivin splice variants regulate the balance between proliferation and cell death[J].Oncogene,2005,24(12):1994-2007.

二级参考文献8

  • 1ho R, Asami S, Motohashi S, et al. Significance of survivin mRNA expression in prognosis of neuroblastoma [J~. Biol Pharm Bull, 2005 28(4) :565-568.
  • 2Wang J, Lenardo M J. Roles of Caspases in apoptosis, development and cytokine maturation revealed by homozygous gene deficiencies [J]. J Cell Sci,2000, 113(5) :753-757.
  • 3Hall P A, Lane D P. P53 in tumour pathology: can we trust immunohisto-chemistry? Revisited [J] ! J Pathol, 1994,172 (1):1-4.
  • 4Slaz W, Eisenberg D, Plescia J, et al. A survivin gene signatures predicts aggressive tumor behavior [J]. Cancer Res,2005,65(9) : 3531-3534.
  • 5Du C, Fang M, Li Y, et al. Smac, a mitochondrial protein that promotes eytoehrome c-dependent easpase activation by eliminating IAP inhibition [ J ]. Cell, 2000,102 ( 1 ) : 33 -42.
  • 6Ku J H, Kwak C, Lee H S, et al. Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder [J]. J Urol, 2004,171(2) :631-635.
  • 7Hoffman W H, Biade S, Zilfou J T, et al. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 [J]. J Biol Chem, 2002, 277: 3247-3257.
  • 8Mirza A, McGuirk M, Hockenberry T N, et al. Human survivin is negatively regulated by wild-type p53 and participates in p53- dependent apoptotic pathway [J ]. Oncogene, 2002,21 (17) : 2613 - 2622.

共引文献5

同被引文献43

  • 1侯燕,胡群,刘爱国,张柳清.Survivin及其变异体在儿童急性淋巴细胞白血病中的表达及意义[J].中国医师进修杂志(内科版),2006,29(3):38-40. 被引量:2
  • 2侯燕,胡群,刘爱国,张柳清,刘双又.survivin在儿童急性白血病细胞中的定位表达及与化疗的关系[J].中国当代儿科杂志,2006,8(2):101-104. 被引量:2
  • 3Guo-Ying Miao Qi-Ming Lu Xiu-Lan Zhang.Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells[J].World Journal of Gastroenterology,2007,13(8):1170-1174. 被引量:50
  • 4Mita A C, Mita M M, Nawrocki S T, et al. Survivin:key regulator of mitosis and apop-tosis and novel target for cancertherapeutics [J]. Clin Cancer Res, 2008,14(16) : 5000-5005.
  • 5Ku J H, Godoy G, Amiel G E, et al. Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review [J]. BJU Int ,2012, [ Epub ahead of print.
  • 6Altieri D C. Survivin and IAP proteins in cell-death mechanisms [ J ]. Biochem J, 2010,430(2) : 199-205.
  • 7Ryan B M, O'Donovan N, Duffy M J. Survivin: A new target for anti-cancer therapy [J]. Cancer Treat Rev, 2009, 35(7) :553-562.
  • 8Wang Y H, Chiou H Y, Lin C T, et al.Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwan Residents population [J]. Urology, 2009,73 (3) : 670-674.
  • 9Zhao J, Wang Z Q, Wang X Y, et al. Preliminary dtudy of fiagnostic utility of mo-lecular beacons in bladder cancer [J]. Urology, 2010,76(2):512. e8-13.
  • 10Weikert S, Christoph F, Schrader M, et al. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients andits potent-ial relevance for disease detection and prognosis [J]. Int J Cancer, 2005,116( 1 ) : 100-104.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部